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Abstract-A chemoenzymatic synthesis of homogeneous neoglycoproteins and glycopeptides was explored using 
oligosaccharyltransferase isolated from yeast. Neither the microsomal form nor the solubilized form of the enzyme catalyzed the 
transfer of the core Glc~Man~(GlcNAc)~ oligosaccharide to chemically modified ribonuclease A or a-lactalbumin. Similarly, no 
transfer was observed to the 32-amino acid peptide hormone, calcitonin, by either the membrane-bound or soluble form of 
oligosaccharyltransferase. However, a 17-amino acid fragment of yeast invertase with the unusual sequence containing two 
overlapping glycosylation sequons proved to be a good substrate, slightly less effective than the well studied tripeptide, Bz-Asn- 
Leu-ti-NH2. Product analysis using gel permeation chromatography showed that the expected glycopeptides were formed and 
en& H-catalyzed cleavage of the oligosaccharide portion from the glycopcptides demonstrated that the glycopeptides contained 
the same carbohydrate moiety. 
Introduction 
Oligosaccharyltransferase (OST, EC 2.4.1.119) 
catalyzes the reaction shown in Equation 1. This is a 
co-translational process, occurring in the endoplasmic 
reticulum as the growing peptide is exiting the 
ribosomal complex.* In addition, this is an unusual 
chemical reaction involving apparent nucleophilic 
attack by an amide nitrogen on C-l of the terminal 
sugar in a lipid-linked oligosaccharide. The literature 
contains a large body of data on the biochemistry and 
enzymology of the biosynthesis of the lipid- 
oligosaccharide (LOS) substrate, i.e. the so-called 
dolichol cycle2 as well as the glycosidases and 
glycosyltransferases involved in the processing of the 
initial product of Equation l.3v4 However, much less is 
known about the detailed biochemistry of the OST- 
catalyzed reaction, e5 the purification of a multiprotein 
complex required for catalysis of Equation 1 has been 
reported only recently.6*7 This complex, isolated from 
canine pancreas, consists of three non-identical 
subunits: 66 kDa (ribophorin I), 63 kDa (ribophorin II), 
and 48 kDa. A very exciting result of this purification is 
the finding that the mammalian 48 kDa protein has 25 
% identity to an essential yeast protein, WBPl.7 
Independent studies have shown that WBPl is not only 
essential for yeast OST activity but is also critical for 
yeast replication.gvg These experimental data point to 
the key role of N-linked glycosylation in cell survival 
although the exact role of the oligosaccharides in 
glycoprotein function is not understood.*0-13 
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We have initiated a research program aimed at 
understanding the mechanism of the reaction catalyzed 
by OST. Prior work in several laboratories has shown 
that small peptides are effective OST substrates.14-16 
Less extensive studies have indicated that truncated 
lipidoligosaccharides can be used as oli 
P 
osaccharide 
donors in the OST-catalyzed reaction.‘“’ In addition, 
solubilization of the membrane-bound OST activity 
leads to good recovery of activity and allows for the 
initial quantitative characterization of the OST- 
catalyzed reaction in terms of substrate structural 
requirementsI Mn2+- and pH-dependence,19 and the 
stimulation of OST activity by membrane lipids.*“**’ In 
our initial research, we have used both biosynthetic 
LOS** and the chitobiose derivative, a 
lipiddisaccharide (LDS),23 in order to establish 
rigorously the structure of the glycopeptide product. We 
have also used chemically synthesized LDS to effect an 
OST-catalyzed glycosylation of the tripeptide, Bz-Asn- 
Leu-Thr-NH?, on a sufficiently large scale so as to 
allow for comparison of the chemoenzymatic product 
with the chitobiose-containing glycopeptide which was 
also synthesized via a more classical non-enzymatic 
route.23 We have used this system to explore two 
possible catalytic mechanisms by looking for deuterium 
wash-out during OST catalysis. Glycopeptides isolated 
from OST-catalyzed glycosylation of *H-labeled peptide 
substrates were analyzed by ‘H NMR and no *H wash- 
out was observed, thus ruling out two ‘nucleophilic 
activation’ mechanisms of OST cata1ysis.24 
The present research focuses on the use of OST to 
catalyze the glycosylation of proteins and large 
peptides. We wished to use homogeneous 
neoglycoproteins and/or glycopeptides for NMR studies 
which would address the influence of appended 
carbohydrates on the structure of the protein moiety of 
N-linked glycoproteins. Conversely, the influence of the 
surrounding protein on the structure of a pendant 
oligosaccharide could also be studied. In a manner 
analogous to the chemoenzymatic synthesis employed 
in our recent NMR studies of glycopeptides,‘4 we would 
be able to access sufficient quantities of the desired 
neoglycoproteins using OST as the catalyst. We were 
encouraged by two papers from the Lennarz group in the 
late 1970s which reported the OST-mediated 
glycosylation of chemically modified ribonuclease A 
(RNase A), a-lactalbumin (a-Lac), and ovalbumin.2sT26 
Of particular interest was the report of the ability to 
glycosylate RNase A since there is a tremendous 
amount of structural information on the non- 
glycosylated form (RNase A) of this extensively studied 
enzyme. Very little structural information is available 
on the glycosylated form, RNase B.‘7 In this paper, we 
report the results of our studies on the use of OST to 
effect the glycosylation of proteins and large peptides. 
Results 
In the present work we have investigated the 
glycosylation of modified proteins and large peptides in 
a reaction catalyzed by oligosaccharyltransferase 
(OST) isolated from yeast. As a prelude to more 
extensive investigations using purified OST, we wished 
to compare the microsomal and solubilized forms of the 
enzyme in these reactions. In order to establish that the 
solubilized enzyme led to the synthesis of the same 
glycopeptide product as that obtained from the 
microsomal form, the tripeptide substrate, Bz-Asn-Leu- 
Thr-NH2, was glycosylated using 3H-labe11ed 
lipidoligosaccharide (“H-LOS). The glycopeptide was 
isolated and analyzed by gel filtration chromatography 
as previously described. 20*22 The chromatographic data 
shown in Figure I are very similar to those previously 
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Figure 1. Gel filtration (Bio-Gel P-4) of glycopeptide. product obtained from solubilized OST-catalyzed glycosylation of Bz-Asn-Leu-Thr-NH Z by 
13Hlu3s. 
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reaction catalyzed by the microsomal enzyme.22 Thus, 
solubilization of the membrane-bound OST leads to a 
functional enzyme which is able to catalyze the 
reaction of interest. With these data in hand, the 
comparison of microsomal vs solubilized OST as 
catalysts for the glycosylation of proteins was initiated. 
As noted in the Introduction, data in the literature 
indicated that several proteins were substrates only if 
they were modified by chemical methods.25*26 The data 
given in Table 1, Section A, show that the modified 
proteins are extremely poor OST substrates. Comparison 
of the distribution of 3H in various fractions after OST- 
catalyzed glycosylation of endogenous P40 proteins, i.e. 
no added tripeptide substrate (line l), vs that observed 
in the presence of the tripeptide (line 2) shows, as 
expected, the almost complete inhibition of protein 
glycosylation (SDS-soluble) in favor of peptide 
glycosylation (HZO-soluble). It was expected that OST- 
catalyzed glycosylation of the exogenous modified 
proteins would lead to an increase of the 3H transferred 
from [3H]LOS to glycoproteins (SDS fraction). 
Surprisingly, a marked decrease in the 3H-labelled 
glycoprotein was observed when the modified proteins 
were used as potential OST substrates. These data 
suggest that the modified proteins are capable of 
inhibiting the glycosylation of endogenous proteins but 
that the former are not themselves effective OST 
substrates. This conclusion was confirmed by direct 
analysis of the reaction mixtures by polyacrylamide gel 
electrophoresis (PAGE) and by Bio-Gel P-6 
chromatography as described in the Experimental 
Section. Only 3H-LOS was observed as a distinct peak; 
less than 2 % of the applied radioactivity eluted as 
expected for the desired glycoproteins (data not shown). 
Similar analysis of both the H20-soluble and SDS- 
soluble fractions by PAGE and Bio-Gel P-4 
chromatography demonstrated the absence of 3H- 
labelled glycoproteins in those specific fractions. 
We have also carried out similar experiments with 
solubilized OST activity, isolated as described in the 
Experimental Section. The data in Table 2, Section A, 
lead to the same conclusions as those just described for 
the microsomal enzyme, i.e. neither sulfttolyzed nor S- 
carboxamidomethyl RNase A is a substrate for the 
solubilized OST. In contrast, the data of Table 2 show 
that Bz-Asn-Leu-Thr-NH2 is a good substrate leading to 
the expected glycopeptide product (Figure 1) as already 
discussed. 
While the failure to observe significant glycosylation of 
modified proteins was a disappointment in terms of 
using this chemoenzymatic approach for the synthesis 
of homogeneous neoglycoproteins, it seemed 
appropriate to ascertain what structural limitations are 
associated with OST-catalyzed protein/peptide 
glycosylation. Prior reports in the literature are in 
conflict as to the ability of calcitonin, a 32-amino acid 
hormone, to serve as an OST substrate.14*28 This peptide 
Tabk 1. 3H-Labelled products (46) obtained from reaction mixtures using various protein or peptide subsaates, 13HlLOS, and microsomal OW 
















+ 22.8.20.9 11.1.12.0 35.5,38.7 30.5.28.4 
360 + 18.1.24.9 27.8,29.2 48.4.39.9 5.6, 6.0 
140 + 26.4,27.0 23.5,24.5 41.2, 38.2 8.8, 10.3 
140 + 29.4.24.1 42.1.46.1 24.0.23.8 4.4, 6.1 
140 + 29.1.28.6 33.7.33.9 29.3.30.2 7.8, 7.2 
+ 22.3.24.4 12.8. 18.4 41.1.32.7 
150 + 28.4 16.4 327 
+ 31.7.21.9 22.6.24.4 12.7. 10.2 
150 + 27.9 23.8 33.6 
+ 8.9, 9.3 15.7, 18.1 35.5,35.6 39.9.36.9 
360 + 11.2. 14.2 39.6.38.3 38.5.35.6 10.7, 11.9 





‘For scheme showing separation of substrates and products in addition to details of the separation procedure, see Clark era1.22 Incubation time for 
modified proteins, 2 h; for calcitonin, 90 min; fat invertase peptides, 30 min. bAbbreviations used for protein or peptide substrates: RA-(SSOj-)s. 
sulfitolyzed ribonuclease A; Lac-(SCH2COs-)s, S-carboxymethylated a-lactalbumin; Lac-(SCH 2CONH2)s, S-carboxamidomethylated a- 
lactalbumin; IVT-Am, peptide corresponding to yeast invertase sequence from 82-98. IVTGln, peptide corresponding to yeast invertase sequence 
from 82-98 except with Gln in place of Asn . 92 ‘Lipid-linked carbohydrates containing ‘H-mannose derived from ‘H-LOS biosynthesis. 
dGlycopeptide. Wueacted ‘H-LOS substrate. ‘Glycoproteins. sAssay run in the presence of 10 mhl DTT. 
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Table 2. ‘H-Labelled products (96) obtained from reaction mixtures using various protein or peptide substrates, [3H]LOS. and solubilized OST’ 










70% MeOHC 1103* SDSC 
11.4,11.4 37.8,3 1.4 50.8.57.1 
73.8.72.8 13.3, 15.0 13.0, 12.2 
8.6 43.9 47.5 
8.9, 15.5 37.2.28.3 53.9,56.1 
@V 
None 11.9, 16.2 61.7.57.4 26.3,26.5 
Bz-AmLeu-Thr-NH* 360 39.7.37.9 47.9.49.8 12.4. 12.3 
Calcitonin 150 14.6 61.3 24.1 
IVT-Am 360 33.9.30.3 5 1.9.55.7 14.2, 14.0 
IWGln 360 16.4, 19.5 60.6. 57.4 23.0,23.1 
‘Separation of substrates and products performed as described by Chalifour and Spiro.zo Incubation time for modified protein substrates, 2 h; for 
calcitonin and invertase oentide substrates. 30 min. bAbbreviations used for substrates are given in Table 1, footnote ‘b’. %lycopeptide. 
contains one glycosylation site within a disulfide loop: 
. . . -Cys-Ser-Asn-Leu-Ser-Thr-Cys-..., but this is not 
glycosylated in vim. As shown in Table 1, Section B, 
the lack of significantly increased radioactivity in the 
glycopeptide fraction (H20) indicates that calcitonin 
failed to act as an OST substrate. In addition, it should 
be noted that the glycoprotein fraction (SDS) was not 
significantly reduced in the presence of calcitonin (line 
2) vs that observed in the absence of calcitonin (line 1). 
In order to ascertain if the disulfide loop is an 
impediment to glycosylation, the reactions were 
repeated in the presence of dithiothreitol (D’IT). The 
data shown in Table 1, Section B, again show no 
significant increase in the formation of glycopeptide 
(Hz0 fraction) when calcitonin was assayed as a 
possible substrate in the presence of DTT. The 
glycosylation of endogenous protein appears to be 
markedly reduced in the presence of calcitonin (line 4) 
vs that observed in the absence of calcitonin (line 3). 
However, the effects of DTT on the variety of acceptor 
proteins and/or the LOS substrate are not well studied. 
Thus, the distribution of radioactivity in the non-peptide 
control (line 3) is not well documented in terms of 
structural identification of products. The absence of 
significant OST-catalyzed glycosylation of calcitonin 
was confirmed by gel chromatography as described in 
the Experimental Section; no radioactivity was 
observed other than that which could be attributed to 
the 3H-LOS substrate. Similar results for calcitonin were 
obtained with solubilized OST (Table 2). 
The multiple glycosylation sites in invertase have been 
investigated in detail by Maley and co-workers.*” Of the 
14 potential glycosylation sites, seven are always 
glycosylated while six are glycosylated to varying 
degrees. One site (Asn93) is never glycosylated and is 
part of an unusual pair of overlapping sequons, . ..Asn9’- 
Asn93-Tbr-Ser- . . . . In collaboration with Dr Maley, we 
have initiated an investigation of the OST-catalyzed 
glycosylation of invertase peptides. Our first efforts have 
involved a 17-amino acid peptide containing the 
overlapping sequons. As shown in Table 1, Section C, 
both the parent peptide containing the overlapping 
sequons, IVT-Asn, and a synthetic ‘mutant’ peptide, 
IVT-Gln, containing Gln in place of Asn92, result in 
significant formation of glycopeptide. As shown 
previously, glycopeptides appear in the Hz0 fraction. 
Competition for the OST active site results in decreased 
glycosylation of endogenous P40 proteins, thus leading 
to a decrease in the SDS fraction containing the 
glycoproteins. Similar results for the invertase peptides 
were obtained with solubilized OST (Table 2). A 
graphical representation of the data in Table 2, Section 
B, is shown in Figure 2. These data show that 
glycosylation of IVT-Asn proceeds at a somewhat 
slower rate than glycosylation of Bz-Asn-Leu-Thr-NHz, 
but at a faster rate than IVT-Gln. Glycosylation of 
calcitonin is insignificant under these reaction 
conditions. 
Characterization of the glycopeptide product obtained 
from OST-catalyzed glycosylation of the invertase 
peptides, IVT-Asn and IVT-Gln, was carried out as 
previously described for the tripeptide substrate, Bz- 
Asn-Leu-Thr-NH 2.** Gel chromatography of the HzO- 
soluble glycopeptide product showed a broad peak 
eluting at a position consistent with the size of the 
anticipated glycopeptides (Figure 3). Removal of the 
carbohydrate by endu H-catalyzed hydrolysis leads to 
the identical oligosaccharide domain from both 
glycopeptides as shown in Figure 4. Consistent with the 
data of Tables 1 and 2, and also Figure 2, the amount of 
glycopeptide (Fig. 3) and derived oligosaccharide (Fig. 
4) is markedly reduced for IVT-Gln vs IVT-Asn. 
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Figure 2. Conversion of peptides to giycopeptides based on the incorporation of ‘H from [ ‘H]LOS Into [3Hjglyc.opeptides using solubilized OST 
and a 30 min incubation at ambient temperature. Data shown are the average of duplicate determinations for each peptide as given in Table 2, 
Section B. 1. Bz-Asn-L&u-Thr-NH 2; 2. IVT-Asn; 3. IVT-Gin; 4. caicitonin. 
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Figure 3. Gel filtration (Bio-Gel P-6) of glycopeptide product obtained from microsomal OST-catalywf glycosylation of the invertase peptides, 
IVT-Asn(0)orIVT-Gln(*)by13~. - - - - - 
Discussion 
In an attempt to develop a chemoenzymatic synthesis 
of homogeneous neoglycoproteins, we have investigated 
the oligosaccharyltransferase-catalyzed reaction 
between lipid-linked oligosaccharides and several 
modified proteins or peptides. The reactions have been 
studied using both microsomal and solubiiized OST. 
Several modified proteins were assayed as potential 
OST substrates, using both the microsomal (Table I) 
and solubilized enzyme (Table 2). As previously 
reported,*2 the tripeptide, Bz-Asn-Leu-Thr-NH2, is a 
good substrate and its glycosylation competes with the 
glycosylation of endogenous proteins of the microsomal 
P40 fraction. This competition is shown in Section A of 
Tables 1 and 2 for the microsomal and solubilized OST 
activity, respectively. Thus, with the microsomal OST 
(Table l), ca 30 96 of the 3H is glycoprotein (SDS 
fraction) in the absence of tripeptide substrate, whereas 
in the presence of tripeptide substrate, only ca 5 % of 
1138 
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Figure 4. Gel filtration (BioGcl P-6) of endo H-treated glycopeptide derived from IVT-Asn (0) or IVT-Gin (+ ). Glycopeptide substrate for endo 
H-catalyzed hydrolysis was purified as shown in Figure 3. Arrows I and II indicate the elution volume for the ‘JC-labelled oligosaccharides. 
Gl~~I’~CjMang(GlcNAc)~ and [14C]M~(GlcNAc)2. respectively. 
the 3H is in the SDS fraction. Similar competition 
between the tripeptide substrate and the endogenous 
P40 proteins is observed with the solubilized OST 
activity (Table 2, Section A) where the glycoprotein 
fraction (SDS) is dramatically decreased from ca 55 % 
in the absence of tripeptide to ca 13 % in the presence 
of tripeptide substrate. As shown in Figure 1, the 3H- 
labelled glycopeptide isolated from the reaction mixture 
using solubilized OST has very similar chromatographic 
properties (Bio-Gel P-4) as previously described by us 
for the glycopeptide derived from the same substrates 
using microsomal 0ST.22 The data of Section A of 
Tables 1 and 2 show clearly that the modified proteins 
are very poor substrates for OST-catalyzed 
glycosylation. Product analysis using PAGE as 
described in the Experimental Section showed c 2 % 
3H migrating in the gel at the position anticipated for 
the expected glycoproteins. When the reaction mixtures 
were analyzed directly by gel filtration chromatography, 
c 2 % of the 3H from the 3H-labelled substrate was 
observed at the expected elution volume of the 
presumed glycoprotein product; only [3H]LOS was 
eluted from the column. Most interesting is the apparent 
inhibition of endogenous protein glycosylation (SDS) by 
the added modified proteins, i.e. Table 1, Section A, 
lines 3, 4, 5 vs line I. These results indicate that the 
modified proteins are very poor OST substrates but that 
they may be able to compete with endogenous proteins 
for the OST enzyme. Additional experiments must be 
done in order to obtain more extensive data to 
substantiate further this observation. 
To reduce the high background radioactivity observed in 
the Hz0 fraction in the presence or absence of 
microsomal OST (P40), the usual extraction 
procedure22 was modified slightly in selected 
experiments. The initial pellet obtained by quenching 
the reaction with CHCl3:MeOH (2:1), was resuspended 
in ‘1103’ (CHC13:MeOH:H20, 1:1:0.3) in order to 
extract the unreacted [3H]LOS more effectively. This 
was followed by washing of the 1103-insoluble material 
with H20 (pH 4, HOAc) and dissolving the 3H-labelled 
glycoprotein pellet in SDS. Although the modified 
procedure was effective in lowering the background 
radioactivity noted above, in no case did this modified 
procedure alter the amount of 3H-labelled glycoprotein 
as monitored by gel filtration chromatography or PAGE. 
As a result of the experiments using modified proteins 
described above, we chose to investigate somewhat 
smaller peptides as potential OST substrates in order to 
explore the size limitations imposed by the OST active 
site. Calcitonin has been re orted to be an OST 
P substrate2* or a non-substrate. 4 Our results with both 
the microsomal (Table 1) and solubilized (Table 2) 
OST activity show clearly that there is no evidence for 
glycosylation of calcitonin under these conditions. 
Addition of DTT (10 mM) to the assay in order to 
reduce the disulfide bridge did not affect the results 
(Table 1, Section B). However, the next series of 
potential peptide substrates proved to be much more 
effective. As shown in Section C of Tables 1 and 2, two 
17-amino acid peptides, IVT-Asn and IVT-Gln, derived 
from the invertase sequence containing two overlapping 
sequons,‘9 are effective substrates. In comparison with 
the widely used tripeptide, Bz-Asn-Leu-Thr-NH,, the 
invertase-derived peptide, IVT-Asn, which retains the 
unusual overlapping sequons, is only slightly less active 
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(Fig. 2). In contrast, the ‘mutant’ peptide in which Gln 
replaces the Asn of the first of the overlapping sequons, 
is markedly less active. Further characterization of the 
glycopeptide products derived from OST-catalyzed 
glycosylation of IVT-Asn and IVT-Gln involved gel 
filtration chromatography of both the HzO-soluble 
glycopeptide fraction before (Fig. 3) and after (Fig. 4) 
endo H-catalyzed hydrolysis of the 1 -_) 4 
intersaccharide bond of the chitobiose moiety in the 
oligosaccharide portion of the glycopeptide. Both 
invertase-derived peptides are converted to similar 
glycopeptide products (Fig. 3) containing the same 
oligosaccharide structures (Fig. 4). We are currently 
investigating methods for the rapid detonation of the 
glycosylation site(s) in these and other invertase- 
derived peptides. 
The results presented in this paper show clearly that 
large proteins, even when chemically modified, are not 
good substrates for OST-catalyzed glycosylation and 
therefore cannot be converted to homogeneous 
neoglycoproteins by this method. However, the finding 
that two peptides derived from invertase are OST 
substrates provides the foundation for a systematic study 
of the varied ability to glycosylate apparently 
competent sequons in invertase and, by extension, other 
glycoproteins. Although others have carried out limited 
structure-activity studies on several peptide 
substrates,14-16 the recently developed combinatorial 
approaches to peptide synthesis and the use of peptide 
libraries should allow us to carry out efficient and rapid 
screens of the peptide-binding domains of OST. 
Experimental Section 
General 
Previous papers from this laboratory22*23 contain 
procedures for the synthesis of peptide substrates, 
glycopeptide products, assay for microsomal OST 
activity, chromatographic analyses, and the source of 
radiolabelled compounds. P40 yeast microsomes and 
13H]LOS were prepared as described by Clark et ~1.~~ 
Initially, solubilization of microsomal OST activity was 
carried out using NP-40 according to a slight 
modification of the procedure of Sharma et a1.lQ This 
solubilized preparation was used in studies with the 
tripeptide, Bz-Asn-Leu-Thr-NH2, as substrate. 
Subsequent experiments using modified proteins and 
larger peptides as substrates employed solubilized OST 
from salt-stripped microsomes as described below. All 
glycopeptide products derived by solubilized OST- 
catalyzed glycosylation of Bz-Asn-Leu-Thr-NH2 were 
isolated as described by Chalifour and Spiro20 except 
that a Dowex cation exchange step was omitted. 
Calcitonin was purchased from Bachem. Two peptides 
containin 
99 
overlapping sequons 4 and 5 from yeast 
invertase were provided by Dr Frank Maley, New 
York Department of Health, Albany, NY. The two 
peptides have the sequence Ala-Phe-Ser-Gly-Ser-Met- 
Val-Val-Asp-Tyr-AsnlGln-Asn-Thr-Ser-Gly-Phe-Phe and 
are referred to as IVT-Asn and IVT-Gln depending 
on the amino acid present at the first putative 
glycosylation site. IVT-Asn and IVT-Gln were dissolved 
in DMSO at a concentration of 7.2 mM and the OST- 
catalyzed reaction was run and the products analyzed 
as described previously.22 
Solubiiization of OST activity from salt-stripped yeast 
microsomes 
A suspension of 800 pL of yeast microsomal P40 (40- 
80 mg/mL)22 was diluted to 20 mL with 20 mM T&-Cl 
(pH 7.4), 500 mM NaCI, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), and protease inhibitor cocktail (PIC) 
as described by Kelleher et a1.6 The suspension was 
centrifuged at 184,000 g,, for 45 min in a Beckman 
Ti50 rotor to obtain salt-stripped membranes as the 
pellet. The pellet was resuspended in 800 pL of 50 mM 
Tris-Cl (pH 7.4) buffer containing 5 mM MgC12,5 mM 
MnCl2 buffer. This suspension was stored under N2 at 
-80 “C. 
Solubilization of the OST activity in the salt-stripped 
microsomes employed a modi~cation of the method 
described by Chahfour and Spiro for the solubilization 
of OST activity from calf thyroids.20 A stock solution of 
1.6 % (w/v) NP-40 was prepared in 50 mM Tris-Cl, pH 
7.5,5 mM MgCI2, and 5 mM MnC12. To 200 pL of sah- 
stripped microsomal suspension was added 200 pL of 
the 1.6 % NP-40 stock solution. The suspension was 
homogenized in a Dounce homogenizer (5 strokes), and 
the detergent extract was clarified by cen~ifugation for 
1 h at 158,000 g at 4 “C in a Beckman Ti70.1 rotor. The 
supernatant was extracted and used immediately in 
assays . 
Preparation of modified proteins 
Sulfitolysis of RNase A. RNase A (bovine pancreas, 10 
mg) was dissolved in 1.5 mL of 5 mM HCI, and was 
dituted with 2.5 mL of I mM HCI. SuifitoIysis was 
carried out following the procedure of Pechere er ~1.30 
To remove the chemical reagents, the mixture was 
dialyzed against 2 L of 50 mM Tris-CI buffer, pH 7.5. 
The buffer was changed every 4-S h in order to increase 
the efficiency of the dialysis. The concentration of 
sulfitolyzed RNase A (RA-(SSOs-)8) in the dialysis bag 
was checked by UV (E2m * 5%~ = 7.0). After 30 h dialysis, 
the RA-(SS@-)a solution was concentrated on a 
Microcon centrifugal filtration unit (Amicon) device 
(MWCO 10,000) to achieve a concentration of 3-5 
mg/mL in 50 mM Tris buffer, pH 7.5. The solution was 
stored at below 0 “C, and was used as the source of RA- 
(ss03-)g in g@Zosyhth aSays. 
Analysis of the conversion of RNase A to RA-(SSOj-)8 
was carried out by denaturing (SDS) poiya~ryl~ide 
gel electrophoresis (PAGE) run at a concentration of 15 
410 acrylamide. Glutathione (GSH)-mediated conversion 
of RA-(SSG3-)a back to RNase A was carried out by the 
method of ~annhau~r and Scheraga.3t All samples for 
electrophoresis were prepared in the absence of p- 
mercaptoethanol. 
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Alkylation of a-lactalbumin. a-Lactalbumin was 
dialyzed against distilled water overnight to remove 
salts and stabilizing reagents prior to the 
carboxymethylation reaction, carried out as described 
by Brew et al.32 
Purification of RA-(SSO3-)a and S-carboxymethylated a- 
lactalbumin (Lac-(SCH2CO2-)~) 
Sulfitolyzed RNaseA and S-carboxymethylated a- 
lactalbumin were prepared by the procedures described 
above. At the end of the reaction, the reaction mixture 
was dialyzed against Hz0 for 3 days and lyophilized. 
Lyophilized RA-(SSOJ-)8 or Lac-(SCH2CG2-)8 (10 mg) 
was dissolved in 1 mL of 0.1 M NaHCO3. The filtered 
solution was loaded onto a Sephadex G-75 column (1.5 
cm x 60 cm) at 4 oC.33 The column was eluted with 0.1 
M NaHC03 at a flow rate of 15 mL/h. Fractions of 2 mL 
were collected and checked for absorbance at 280 nm. 
For Lac-(SCH2C02-)a, the fractions with UV 
absorbance were pooled and dialyzed against Hz0 
overnight. After lyophilization, the purified material was 
dissolved in 50 mM Tris-Cl, pH 7.5 at a concentration 
of 5 mg/mL. For RA-(SS@-)a, the pooled fractions 
were loaded onto a Microcon centrifugal unit (Amicon) 
device (MWCO 10,000) for buffer exchange, 
accomplished by washing with large quantities of 50 
mM Tris-Cl, pH 7.5 buffer. The final solution of purified 
RA-(SS@-)s had a concentration of -3 mg/mL in Tris 
buffer. 
Microsomal P40 assay with modified proteins as 
substrates 
Assay mixture contained 8,000-12,000 dpm of dried 
[3H]LOS, 50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 5 
mM MnCl2, 1 % (v/v) Triton X-100, 5 % DMSO, and 
salt-stripped microsomal P40 (100-200 pg of proteins) 
in a volume a of 100 pL. The modified proteins, RA- 
(SSO3-)s and Lac-(SCH2C02-)8, (200 pg) were added 
and the reaction mixture was incubated at ambient 
temperature for 2 h with vigorous gyroshaking (250 t-pm) 
and the reaction stopped by the addition of 3 mL of cold 
CHC13:MeOH (2:l). The separation of the reaction 
products followed procedures described earlier22 with 
the exception that extraction of the glycosylated 
modified protein was carried out at pH 4.0 in order to 
improve the solubility of the extracted product. 
OST assay with modified proteins as substrates using 
NP40-solubilized enzyme 
A 1.35 mg/mL phosphatidylcholine (PC) solution was 
prepared by drying the stock PC ether solution (Sigma, 
100 mg/mL) in a Speed Vat vacuum centrifuge, then 
redissolving the residue in a 50 n&l Tris-Cl, pH 7.5 
buffer solution containing 5 mM MgC12, 5 mM MnCl2, 
and 0.3 % NP40. The OST assay mixture contained 
8,000-12,000 dpm of dried [3H]LOS, 50 mM Tris-HCl, 
pH 7.5, 5 mM MgCl2, 5 mM MnCl2, 0.2 % (v/v) Triton 
X-100, 90 pg of phosphatidylcholine, 0.2 % NP40, 
solubilized OST (30-50 pg), and exogenous proteins 
(50-200 pg ) in a volume of 100 pL. Isolation of the 
glycoprotein roducts was carried out as described in 
the literature. 8 
Analysis of the protein glycosylation assays by 
polyacrylamide gel electrophoresis (PAGE) 
Assays with 10,000 dpm of [3H]LOS, 200 pg of salt- 
stripped P40 and 100 pg of exogenous protein were 
prepared and incubated as usual. At the end of the 
incubation, the assay was diluted by 200 pL of chilled 
50 mM Tris-Cl buffer, pH 7.5 and centrifuged at 12,000 
g for 20 min.2s The supematant was extracted and the 
pellet was washed again. The combined supernatant (no 
more than 500 pL) was transferred into the cup of a 
Microcon centrifugal filtration unit (Amicon), and was 
concentrated at a centrifugal speed of 12,500 g for 1.5 
to 2 h at 4 “C. At this time, 20 pL of electrophoretic 
sample buffer (non-reducing) was added into the 
Microcon cup and vortexed to dissolve any proteins that 
were absorbed to the membrane. The concentrate, 
together with the sample buffer was then removed from 
the Microcon unit and used in electrophoresis. 
Denaturing 15 % acrylamide slab gels (1.5 mm thick) 
were prepared with five large wells so as to 
accommodate the volume of the samples. After the 
samples were loaded, the electrophoresis was continued 
for -1 h until the tracing dye had reached the bottom of 
the gel. The gel was subsequently fixed, stained and 
destained to remove any radioactivity on the surface of 
the gel. Before slicing, the gel was soaked in water for 
15-30 mm to recover the original size. During slicing, 
the gel was first sliced vertically into different lanes. 
The lane of interest was then sliced horizontally into 2 
mm slices on a gel cutter. Each slice was next 
transferred into a 20 mL glass scintillation vial to which 
0.5 mL of Hz0 and 0.5 mL of the tissue solubilizer, 
“Solvable” (NEN), were added. After incubating the 
slices at 50 “C for 2-3 h, 10 mL of scintillation cocktail 
was added into each vial and vortexed vigorously. The 
vials were set at rt overnight before being counted. 
Glycosylation of calcitonin and analysis of the reaction 
products 
The standard assay for peptide substrates2* was 
employed using 50-100 pg of calcitonin (salmon I), and 
salt-stripped microsomal P40 (100-200 pg of proteins). 
When indicated, 10 mM DTT was also included in the 
assay. The incubation was continued at rt for the times 
indicated in Tables 1 and 2. The standard fractionation 
method was used to isolate the glycopeptide product.22 
To analyze the glycosylation products, the reaction was 
quenched with 100 pL of cold 50 mM Tris-Cl, pH 7.5. 
The mixture was centrifuged at 10,000 g for 15 mm. The 
pellet was washed again, and the combined supernatant 
was loaded onto a Bio-Gel P-6 column (1.5 cm x 70 
cm). The column was eluted with 0.1 M NbHC03, pH 
7.5 at a flow rate of 8 mL/l~.~~ Fractions of 1 mL were 
collected and aliquots were counted for radioactivity. 
Bio-Gel P-6 analysis of glycosylated invertase peptides 8. te Heesen, S.; Janetzky. B.: Lehle, L.: Aebi, M. EMBO J. 
1992,11,2071. 
Hz0 fractions from the glycosylation assays of the 
invertase peptides were dried in a Speed Vat vacuum 
centrifuge and redissolved in 500 pL of 0.1 M 
NH4HC03, pH 7.5. After centrifugation, the solution was 
loaded onto a Bio-Gel P-6 column (1.5 cm x 70 cm). 
The column was eluted with 0.1 M NbHC03, pH 7.5 at 
a flow rate of 8mL/h. Fractions of 1 mL were collected, 
and aliquots were counted for radioactivity. Fractions 
containing the putative glycosylated invertase peptides 
were pooled and lyophilized. 
9. tc Heesen, S.; Knauer, R.; Lehle, L.; Aebi, M. EMBO J. 
l!J93,12,279. 
10. Paulsen, J. C. TIBS l!H, 14.272. 
11. Elbein. A. D. TtBTECH 1991, 9,346. 
12. Lodish, H. F. 27ari 1991, 16.374. 
13. Varki. A. Glycobiofogy W3, 3,97. 
14. Ronin, C.; Granier. C.; Case& C.; Bouchilloux, S.; Van 
Rietschoten, J. Eur. J. Biochem 1981, 118,159. 
15. Welply, J. K.; Shenbagamurthi, P.; Lennarz, W. J.; Naider, 
The lyophilized glycosylated invertase peptide (1 ,OOO- F. J. Biol. Chem 1983. 258.11856. 
5,000 dpm) from the previous Bio-Gel P-6 column 
purification was incubated with 50 mIU endo H in 500 
16. Lehle, L.; Bause, E. Biochim Biophys. Acta 1W. 799.246. 
pL of 250 mM Na Citrate, pH 5.5 at 37 “C for 20 h as 17. Lehle. L.; Tanner, W. Eur. J. Biochem 1978. cW, 563. 
previously described22 and the products analyzed by 18. Jackson, B. J.; Warren, C. D.; Bugge, B.; Robbins, P. W. 
Bio-Gel P-6 chromatography as described above. The Arch. Biochem Biophys. 1!%9,272,203. 
column was first calibrated with a sample of 
Glc3[ 14C]Mang(GlcNAc)2 and [14ClMang(GlcNAc)2. 
19. Sharma, C. B.; Lehle, L.; Tanner, W. Eur. J. Biochem 
l!J8l,116,101. 
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